IDNA ETF: iShares Genomics Immunology and Healthcare ETF - Price, Holdings & Analysis
iShares Genomics Immunology and Healthcare ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About iShares Genomics Immunology and Healthcare ETF
What is the current price of IDNA?
The latest IDNA price is $29.25. The 52-week range is $17.26–$31.39. IDNA has returned 46.1% over the past 52 weeks.
What is the expense ratio for IDNA?
IDNA's annual expense ratio is 0.47%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does IDNA pay dividends?
Yes, IDNA pays a 1.06% dividend yield. The last ex-dividend date was 2026-06-20. View full dividend history in the Dividends section.
What are the top holdings of IDNA?
IDNA's largest holdings are Moderna, Inc. (6.8%), Revolution Medicines, Inc (5.7%), Arcellx, Inc. (5.4%) (combined weight: 17.8%). The fund holds 64 total positions. View the complete portfolio breakdown in the Holdings section.
How does IDNA compare to similar ETFs?
Compare IDNA (0.47% expense ratio, $154M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.